KD019
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for KD019, covering 2014-08-01 to 2022-11-08. Get the full timeline:
Most recent: Clinical Trial Update: A Safety, Pharmacokinetic & Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease [Phase 1, Phase 2]